Latest news

Filter by
MEDIA RELEASE: Jan 27, 2023 10:34 AM

Children’s immune response to coronavirus: fast but doesn’t ...

Children have a strong initial immune reaction to coronavirus, but don’t transfer this to long-lasting memory T cells like adults do, new research shows.

Jan 25, 2023 03:04 PM

Pancreatic cancer and brain cancer research projects support...

A new study repurposing an antifungal drug for pancreatic cancer is one of two projects to be boosted by St Vincent’s Clinic Foundation funding.

MEDIA RELEASE: Jan 25, 2023 10:00 AM

Green light for universal COVID-19 vaccine project

A universal vaccine that could bring an end to the COVID-19 pandemic is now in development at the Garvan Institute of Medical Research.

MEDIA RELEASE: Jan 20, 2023 08:55 AM

Genes that cause a rare childhood cancer revealed by Austral...

Australian researchers have created the first genetic map to identify important genes that cause sarcoma, one of the most common cancers in children.

MEDIA RELEASE: Jan 18, 2023 12:45 PM

Poorer health outcomes for at-risk patients with fractures

Patients with complex medical conditions at high fracture risk are vastly undertreated for fracture prevention yet at higher risk of further fracture.

Dec 21, 2022 11:08 AM

Vale Professor Leslie ‘Les’ Lazarus

The Garvan community mourns the passing of a pioneer who shaped its early years.

Dec 20, 2022 03:20 PM

New avenues for precision medicine in lung cancer research

Garvan researcher receives Cancer Australia funding to progress lung cancer prediction and treatment.

Dec 15, 2022 11:03 AM

Garvan researcher wins Highly Commended in the Annual Health...

Prestigious national award recognises Dr Deborah Burnett’s outstanding contribution to health and medical innovation.

MEDIA RELEASE: Dec 14, 2022 04:48 PM

NHMRC awards grants to Garvan researchers

Eight innovative projects will be supported by funding from the National Health and Medical Research Council.

Nov 30, 2022 11:38 AM

CSL Florey Next Generation Award shortlist recognises a risi...

An early career researcher at the Garvan Institute has been selected by the Australian Institute of Policy and Science as one of three finalists for a prestigious biennial award.

MEDIA RELEASE: Nov 29, 2022 09:01 AM

Rogue immune cells linked to leukaemia are a key driver of a...

Scientists have pinpointed rogue immune cells as a major contributor to autoimmune conditions like rheumatoid arthritis and aplastic anaemia.

MEDIA RELEASE: Nov 21, 2022 01:50 PM

Tumour matrix profiling gives clues to progression of some l...

Molecular profiles of the matrix around non-small cell lung cancers identifies which tumours become aggressive and require more targeted treatment.

Nov 18, 2022 12:47 PM

Accelerator Grant for pancreatic cancer researcher

PanKind Foundation supports new study to develop tailored therapy for pancreatic cancer.

Nov 18, 2022 11:29 AM

Garvan researcher announced as a Superstar of STEM

Dr Amanda Khoury will take part in an acclaimed national program, becoming a role model for the next generation of scientists.

MEDIA RELEASE: Nov 08, 2022 10:22 AM

DNA barcoding reveals cancer cells’ ability to evade the imm...

Using DNA barcodes to track cancer cells through time, Garvan scientists have shown that cells within a cancer have diverse abilities to escape immune system defences.

Nov 02, 2022 03:40 PM

Five-year funding for research on new pathways to boost chem...

Associate Professor Robert Weatheritt has been selected as a Viertel Senior Medical Research Fellow.

MEDIA RELEASE: Oct 31, 2022 01:39 PM

World-first gene therapy clinical trial for type 1 diabetes ...

A clinical trial to test how genetically engineered cells might restore insulin function and reduce the need for immunosuppression in patients with type 1 diabetes has been funded.

MEDIA RELEASE: Oct 20, 2022 12:47 PM

Clinical trial will test drug treatment for prevention of de...

A commonly used treatment for diabetes may hold the key to slowing cognitive decline to prevent dementia. This Phase 3 clinical trial is seeking participants.

MEDIA RELEASE: Oct 12, 2022 12:30 PM

Garvan researchers awarded five NHMRC Investigator Grants

The NHMRC has allocated $9 million to fund the critical research projects of five outstanding Garvan researchers.

MEDIA RELEASE: Oct 11, 2022 09:07 AM

Patterns of underlying health issues linked to poorer outcom...

Considering underlying health issues more comprehensively when a patient has a fracture could better identify those at higher risk of poor health outcomes.